Infusion center queue management: chairs, pharmacy, and post-dose

In a conventional clinic, the waiting room and the examination room are two separate spaces: the patient waits in any chair and then occupies the consultation room for a set time. In an infusion center, the waiting chair and the treatment chair are the same thing — and each chair is blocked for the entire duration of the protocol. A ten-chair facility handles, in theory, 80 hours of infusion per day. In practice, with a mix of short (30 min), medium (2 hr), and long (5 hr+) protocols, actual capacity varies widely depending on how the schedule is composed.

Correct management starts with recording the estimated duration of each protocol at the time of booking and allocating chairs as finite assets — the same way a hotel allocates rooms. When a center adopts a digital system with this control, the receptionist can see in real time how many chairs are occupied, how much longer each will be in use, and which queued patient fits into the next available slot. Infusion centers that made this switch report a 15% to 25% increase in effective chair occupancy without adding a single new chair.

The most common mistake in infusion centers is triggering pharmacy preparation when the patient is called to the chair. By that point, the waiting-room time has already elapsed — but the preparation clock only starts now. For compounded chemotherapy agents, preparation takes 45 minutes to 1 hour 30 minutes. For biologics such as adalimumab or tocilizumab, the pharmacist must verify the weight-adjusted dose, product stability, and drug compatibility before releasing the bag. The patient sits in the chair, the nurse places the IV access — and then waits. The chair is occupied, but no infusion is happening.

The solution is to notify the pharmacy at the moment of digital check-in. When the patient scans the QR code at the entrance and confirms the protocol, the system automatically sends a preparation request to the pharmacy: patient name, protocol, and estimated time to chair. Pharmacy has the preparation window without rushing, delivers the bag before the patient needs it, and the chair starts producing output the moment the needle goes in. In infusion centers that implemented this integration, the average time from sitting down to infusion start dropped from 38 to 9 minutes.

An infusion center with ten chairs that schedules an entire morning shift for 8:00 AM creates an impossible queue at opening: ten people arrive together, reception processes all ten check-ins simultaneously, pharmacy receives ten preparation requests at once, and nursing rushes to place ten IV accesses. The practical result is a 40-minute chaos spike followed by a shift where chairs free up unevenly in the afternoon. Staggering arrivals — 8:00, 8:30, 9:00, 9:30 — eliminates the spike without reducing total shift capacity.

With a digital queue and QR code, the patient does not need to arrive exactly at their scheduled time. They scan at the hospital entrance or the parking garage, receive their queue position, and wait for the WhatsApp message: your chair is ready, you can come up now. This is especially relevant for oncology or autoimmune disease patients with reduced mobility or those who arrive with a caregiver — standing in the reception area for 20 minutes is an unnecessary and avoidable discomfort.

Patients on active chemotherapy are immunosuppressed: a low neutrophil count means that exposure to sick people in the waiting room is not an inconvenience — it is a real clinical risk. Physically separating the oncology patient's wait from the general area is not a comfort measure; it is a clinical protocol. Many specialized oncology infusion centers maintain an isolated waiting space or route the patient directly to the chair as soon as it is available, bypassing the common area entirely.

On the legal side, elderly patients (60 and over), persons with disabilities, and pregnant women have the right to priority service under Law 10.048. In an oncology infusion center, the majority of adult patients fall into at least one of those categories. With digital check-in, patients mark their priority category at the entrance, the system automatically places them in the correct queue, and the log is recorded — useful in a Procon inspection, insurer audit, or ANS regulatory assessment.

When the last drop of the IV bag falls, the infusion is finished — but the chair is not yet available. Standard post-infusion monitoring periods vary by protocol: 15 to 20 minutes for iron and antibiotic infusions; 30 to 60 minutes for biologics such as infliximab, which carries a risk of delayed infusion reactions; and up to 2 hours for a first dose of bortezomib or other agents with variable toxicity profiles. Releasing the chair before this period is complete creates clinical risk — and the insurer may challenge the care protocol in an audit.

With a digital queue system, monitoring time is embedded as a mandatory step in the protocol: when the infusion ends, the nurse marks the start of the observation period, the system triggers an alert at the programmed interval and signals when the patient can be discharged. Simultaneously, the caregiver who stepped out receives a WhatsApp notification: the patient is in post-infusion monitoring, estimated discharge in 30 minutes. This eliminates caregiver anxiety and reduces pressure on reception staff.

A no-show for a medical consultation costs one physician's time — 15 to 30 wasted minutes. A no-show at an infusion center with a prepared chemotherapy agent can cost between BRL 3,000 and BRL 80,000 in discarded medication, depending on the protocol. Bevacizumab (BRL 8,000–15,000 per cycle), trastuzumab (BRL 12,000–25,000 per dose depending on formulation), and rituximab (BRL 15,000–30,000 per dose) have post-compounding stability windows ranging from 24 hours to under 4 hours. Prepared and unused within the window: mandatory disposal.

Proactive WhatsApp confirmation — 48 hours in advance and again 2 hours before — reduces no-shows from 12–15% to under 4% in centers that adopt this protocol. For high-cost drug protocols, some centers also implement a pharmacy call to confirm preparation and validate patient presence before starting compounding. The practical rule: the monthly cost of a queue management system with automatic WhatsApp confirmation is less than the cost of two biological drug no-shows per month.

Four indicators define the operational health of an infusion center. The first is chair occupancy rate per shift — target above 80%; below 65%, the schedule needs review. The second is time from check-in to infusion start — target under 25 minutes; above 45 minutes signals a pharmacy-to-chair flow problem. The third is the late-cancellation and no-show rate — target under 5%; above that, the confirmation protocol needs strengthening.

The fourth indicator — and the least tracked — is the incidence of adverse reactions requiring emergency protocol (hypotension, urticaria, anaphylaxis). This is not a queue management number, but it is directly tied to the process: a severe reaction mobilizes the entire team, interrupts ongoing infusions, and can clear the room for one to two hours. Centers that track this indicator can correlate it with specific medication lots, shift times, and on-duty nurses — data that helps investigate root causes before the next event occurs.